A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis
Clinical trial NCT04439526 · COMPLETED
Trial details
- NCT number
- NCT04439526
- Sponsor
- Janssen-Cilag S.p.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-10
- Primary completion
- 2023-11-21
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.